FdaApplication
NDA 216951
Identifiers
- fda_app_no: NDA216951
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND |
| application_type | NDA |
| approval_date | 2023-02-01 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JESDUVROQ | DAPRODUSTAT | 1MG | TABLET;ORAL |
| JESDUVROQ | DAPRODUSTAT | 8MG | TABLET;ORAL |
| JESDUVROQ | DAPRODUSTAT | 4MG | TABLET;ORAL |
| JESDUVROQ | DAPRODUSTAT | 2MG | TABLET;ORAL |
| JESDUVROQ | DAPRODUSTAT | 6MG | TABLET;ORAL |
5 products